Kenvue Inc.
KVUEKenvue Inc. (KVUE) is a consumer health company that focuses on the development, manufacturing, and marketing of well-known health, wellness, and personal care brands. It was established as a separate entity following the spin-off from Johnson & Johnson and aims to leverage its portfolio of trusted brands in skincare, oral care, pain relief, and other consumer health segments.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| November 26, 2025 | $0.21 | 2025-11-12 | 2025-11-12 |
| August 27, 2025 | $0.21 | 2025-08-13 | 2025-08-13 |
| May 28, 2025 | $0.20 | 2025-05-14 | 2025-05-14 |
| February 26, 2025 | $0.20 | 2025-02-12 | 2025-02-12 |
| November 27, 2024 | $0.20 | 2024-11-13 | 2024-11-13 |
Dividends Summary
- Consistent Payer: Kenvue Inc. has rewarded shareholders with 10 dividend payments over the past 2 years.
- Total Returned Value: Investors who held KVUE shares during this period received a total of $2.04 per share in dividend income.
- Latest Payout: The most recent dividend of $0.21/share was paid 58 days ago, on November 26, 2025.
- Yield & Schedule: KVUE currently pays dividends quarterly with an annual yield of 4.65%.
- Dividend Growth: Since 2023, the dividend payout has grown by 3.7%, from $0.20 to $0.21.
- Dividend Reliability: KVUE has maintained or increased its dividend for 10 consecutive payments.
Company News
Johnson & Johnson delivered solid Q4 2025 results with 9.1% revenue growth to $24.56 billion and improved profitability, driven by strong oncology and immunology demand. The company maintains its 'Dividend King' status with a 2.3-2.5% yield and strong balance sheet. Technically, the stock trades above key moving averages with bullish momentum, th...
The article recommends Procter & Gamble and Johnson & Johnson as stable dividend stocks for uncertain market conditions. Both companies are Dividend Kings with 60+ years of consecutive dividend increases, strong cash flows, and resilient business models that perform well across economic cycles.
Coca-Cola, Kimberly-Clark, and Johnson & Johnson are recommended as Dividend Kings with 50+ years of consecutive dividend increases. These companies offer high-yielding dividends (2.5%-5%), strong financial profiles, and growth prospects through organic expansion and strategic acquisitions, making them suitable for passive income investors in 202...
Three stocks have attracted over $100 million in insider buying from prominent institutional investors: DoorDash (Sequoia Capital), Kenvue (Starboard Value LP), and Kymera Therapeutics (Baker Bros. Advisors). While these purchases signal confidence from sophisticated capital, investors should consider offsetting insider sales and the long-term vi...
Target Corporation presents a classic turnaround opportunity as activist hedge fund Toms Capital Investment Management builds a significant stake in the retailer. With the stock down 28% in 2025, Target trades at a low P/E ratio of 12-13x with a strong 4.6-5.0% dividend yield and 57 consecutive years of dividend increases. The timing is critical ...
